EcoDrugPlus

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSBBBG00000016765
Gene Symbol: NQO1
3 Cross references
195 Possible Orthologues:

Nfe2 Like Bzip Transcription Factor 2

Ensembl ID : ENSBBBG00000017780
Gene Symbol: NFE2L2
3 Cross references
216 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSBBBG00000018108
Gene Symbol: NPC1L1
3 Cross references
190 Possible Orthologues:

Pim-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSBBBG00000001676
Gene Symbol: PIM1
3 Cross references
248 Possible Orthologues:

Pim-2 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSBBBG00000024569
Gene Symbol: PIM2
3 Cross references
115 Possible Orthologues:

Rar Related Orphan Receptor C

Ensembl ID : ENSBBBG00000013856
Gene Symbol: RORC
3 Cross references
383 Possible Orthologues:

Rela Proto-Oncogene, Nf-Kb Subunit

Ensembl ID : ENSBBBG00000024071
Gene Symbol: RELA
3 Cross references
200 Possible Orthologues:

Ros Proto-Oncogene 1, Receptor Tyrosine Kinase

Ensembl ID : ENSBBBG00000009903
Gene Symbol: ROS1
3 Cross references
125 Possible Orthologues:

Raf-1 Proto-Oncogene, Serine/threonine Kinase

Ensembl ID : ENSBBBG00000011493
Gene Symbol: RAF1
3 Cross references
224 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSBBBG00000021280
Gene Symbol: ROCK1
3 Cross references
211 Possible Orthologues:

Rho Associated Coiled-Coil Containing Protein Kinase 2

Ensembl ID : ENSBBBG00000011669
Gene Symbol: ROCK2
3 Cross references
298 Possible Orthologues:

Sem1 26s Proteasome Subunit

Ensembl ID : ENSBBBG00000005233
Gene Symbol: SEM1
1 Cross references
156 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).